Logo image of VSEE

VSEE HEALTH INC (VSEE) Stock Earnings & Estimates

USA - NASDAQ:VSEE - US92919Y1029 - Common Stock

0.635 USD
0 (-0.77%)
Last: 9/26/2025, 8:00:02 PM
0.62 USD
-0.02 (-2.36%)
After Hours: 9/26/2025, 8:00:02 PM

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2022 2023 2024 2025 2026
Revenue
YoY % growth
VSEE revenue by date.VSEE revenue by date.
5.766M10.421M
80.74%
16.954M
62.68%
22.045M
30.03%
EBITDA
YoY % growth
VSEE ebitda by date.VSEE ebitda by date.
N/A-1.786M-3.304M
-84.98%
-4.037M
-22.19%
-2.237M
44.59%
EBIT
YoY % growth
VSEE ebit by date.VSEE ebit by date.
-3.59M
-1,182.14%
-1.787M
50.23%
-4.683M
-162.08%
-6.485M
-38.49%
-5.093M
21.47%
Operating Margin
VSEE operating margin by date.VSEE operating margin by date.
N/A-30.99%-44.93%-38.25%-23.10%
EPS
YoY % growth
VSEE eps by date.VSEE eps by date.
N/AN/AN/A-0.37
-1,100.00%
-0.24
33.33%

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q1 / 25 Q2 / 25 Q3 / 25
EPS
Q2Q % growth
-0.12-0.08-0.08
Revenue
Q2Q % growth
4.012M
168.18%
4.159M
142.99%
4.313M
28.58%
EBITDA
Q2Q % growth
-1.434M
-2,292.84%
-885.36K
-349.65%
-853.74K
-11.34%
EBIT
Q2Q % growth
-2.046M
-3,257.59%
-1.497M
-639.44%
-1.466M
-2.09%

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
VSEE Yearly EPS VS EstimatesVSEE Yearly EPS VS EstimatesYearly EPS VS Estimates 2024 2025 2026 -0.1 -0.2 -0.3
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q4 2024
Q2Q % growth
3.859M 3.592M267.4K7.44%
VSEE Yearly Revenue VS EstimatesVSEE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2023 2024 2025 2026 5M 10M 15M 20M
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS0% 0% 0% 0%
Revenue0% 0% 0% 0%